Mabwell (688062.SH), an innovative biopharmaceutical company with entire industry chain, announced that its proprietary CDH17-targeting antibody-drug conjugate (ADC), 7MW4911, has received ...

Dr. Jacob Sands discusses the significance of the FDA approval of Datroway for the treatment of patients with locally ...

Targeted Oncology connects oncology professionals with updates on immunotherapy, biomarkers, cancer pathways, and targeted ...

Think chocolate, eggs, and potatoes are unhealthy? Think again! Discover surprising foods once labeled “bad” that actually ...